Moxilux delivers Moxifloxacin 0.5% — a fourth-generation fluoroquinolone with greater corneal permeation and a dual mode of action against susceptible pathogens.
Its broad-spectrum coverage and superior tissue penetration make it a trusted choice for ocular bacterial infections and peri-operative prophylaxis.
Key Highlights
- Greater corneal permeation
- Dual mode of action
- Broad gram +ve coverage
Indications
The product information on this website is intended for healthcare professionals and is provided for general information only. It does not replace the Instructions for Use (IFU) supplied with each product, which contain the complete indications, contraindications, warnings, and precautions. Always read and follow the current IFU before use. Product availability and regulatory status vary by country; please contact Oculentis Medical for information specific to your market.
